Vaccine Development Platforms

David Loong is our senior consultant, novel modalities APAC, bioprocessing strategy. Previously, David held roles as a senior scientist in biotech startups encompassing cell & gene therapy process development services, mAb discovery, and preclinical development. He has an extensive track record providing contract research services as a senior research scientist at AMRI Global, and as a product custodian for API GMP manufacturing at GSK. He holds a Ph.D. in synthetic organic chemistry from the Australian National University and a BTech(Hons) from Massey University (NZ) specializing in chemistry and process engineering.

Josephine leads RNA therapeutics initiatives across the APeC region, where she fosters customer collaborations, drives innovation, and transforms scientific insights into sustainable go-to-market strategies. With more than 16 years of experience spanning lab management, technology management (chromatography and TFF), customer training, segment market development (plasma, vaccine, mRNA), strategy consultation, and customer applications for novel modalities, Josephine has successfully led cross-functional programs and international partnerships. She is also an active contributor to thought leadership and scientific publications. Josephine holds a Master’s degree in Bio-resources and Agriculture from National Taiwan University, specializing in protein and molecular science.